Israel Akinrinsola

Israel Akinrinsola is a Director in Global Healthcare Investment Banking at Evercore since June 2018, following previous roles as Vice President and Associate in the same sector. Akinrinsola has extensive experience in managing transactions across large pharmaceuticals, biotech, specialty pharma, and pharma services, with a focus on both domestic and cross-border deals in Europe and the US. Notable transaction experience includes advising major firms like Novo Nordisk and Sanofi on significant acquisitions and collaborations. Earlier roles at Barclays Investment Bank and EY included equity research and transaction advisory services, along with a strong foundation in financial modeling and valuation analysis. Akinrinsola holds an MSc in Investment Management from Bayes Business School and is a qualified Chartered Accountant from the Institute of Chartered Accountants Scotland.